Screening for High-Risk Human Papillomavirus Using Passive, Self-Collected Menstrual Blood
- 3 August 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 140 (3) , 470-476
Abstract
OBJECTIVE: To assess concordance and acceptability of a modified menstrual pad compared with a clinician-collected high-risk human papillomavirus (HPV) sample. METHODS: This was a prospective observational study. Women presenting for either cervical cancer screening or with a history of high-risk HPV positivity were eligible. Three samples were requested from participants: 1) clinician-collected cervical specimens; 2) self-collected vaginal swabs; and 3) a modified menstrual pad, which was taken home for use during the next menstruation. All samples were processed using the Cobas HPV test. Menstrual pad dried blood spots were eluted, then similarly processed. RESULTS: Of 153 women enrolled in the study, 106 provided menstrual pad samples and clinician-collected cervical specimens for high-risk HPV analysis. For samples in which the interval between the clinician-collected specimen and the menstrual pad sample was less than 2 months, the concordance was 94% (95% CI 83–98). For women who tested positive for high-risk HPV who presented for general screening and those with more than cervical intraepithelial neoplasia 2, menstrual pad and clinician-collected specimen agreement was 100% (95% CI 32.5–100). Among participants, 22.9% expressed discomfort with the self-collected vaginal swabs and opted out of collection. Overall, 94.0% of participants preferred the menstrual pad over clinician-collected sampling. Twelve patients were found to be positive for HPV on the menstrual pad sample but negative on the clinician-collected specimen. CONCLUSION: Among women who tested positive for HPV, the menstrual pad showed highly concordant results compared with clinician-collected sampling. This collection approach shows promise for integration into cervical cancer prevention programs.Keywords
This publication has 17 references indexed in Scilit:
- Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studiesBMJ, 2015
- Current Cervical Carcinoma Screening GuidelinesJournal of Clinical Medicine, 2015
- Menstrual blood closely resembles the uterine immune micro-environment and is clearly distinct from peripheral bloodHuman Reproduction, 2013
- Feasibility of Community-Based careHPV for Cervical Cancer Prevention in Rural ThailandJournal of Lower Genital Tract Disease, 2013
- Proteomic Analysis of Menstrual BloodMolecular & Cellular Proteomics, 2012
- Invasive Cervical Cancer and ScreeningJournal of Lower Genital Tract Disease, 2011
- Cervical cancer preventionCancer, 2010
- Human Papillomavirus DNA Detection in Menstrual Blood from Patients with Cervical Intraepithelial Neoplasia and Condyloma AcuminatumJournal of Clinical Microbiology, 2010
- Cervical Cancer Prevention—Cervical Screening: Science in EvolutionObstetrics and Gynecology Clinics of North America, 2007
- The natural history of cervical HPV infection: unresolved issuesNature Reviews Cancer, 2007